XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia.

Kim YH, Shim J, Tsai CT, Wang CC, Vilela G, Muengtaweepongsa S, Kurniawan M, Maskon O, Li Fern H, Nguyen TH, Thanachartwet T, Sim K, Camm AJ, XANAP investigators

Open source

DOI: 10.1002/joa3.12073
Published: 2018 Aug
Container: Journal of arrhythmia
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/joa3.12073,
  title = {XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia.},
  author = {Kim YH and Shim J and Tsai CT and Wang CC and Vilela G and Muengtaweepongsa S and Kurniawan M and Maskon O and Li Fern H and Nguyen TH and Thanachartwet T and Sim K and Camm AJ and XANAP investigators},
  year = {2018},
  journal = {Journal of arrhythmia},
  doi = {10.1002/joa3.12073},
  url = {https://doi.org/10.1002/joa3.12073}
}

RIS

TY  - JOUR
TI  - XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia.
AU  - Kim YH
AU  - Shim J
AU  - Tsai CT
AU  - Wang CC
AU  - Vilela G
AU  - Muengtaweepongsa S
AU  - Kurniawan M
AU  - Maskon O
AU  - Li Fern H
AU  - Nguyen TH
AU  - Thanachartwet T
AU  - Sim K
AU  - Camm AJ
AU  - XANAP investigators
PY  - 2018
JO  - Journal of arrhythmia
DO  - 10.1002/joa3.12073
UR  - https://doi.org/10.1002/joa3.12073
ER  -

APA

YH, K., J, S., CT, T., CC, W., G, V., S, M., M, K., O, M., H, L. F., TH, N., T, T., K, S., AJ, C., & investigators, X. (2018). XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia.. Journal of arrhythmia. https://doi.org/10.1002/joa3.12073

Source records

pubmed · retrieved 2026-09-26T10:49:10.308Z